Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net income	$ 8,531	$ 9,156
Adjustments to reconcile net income to net cash provided by operating activities:
Net premium amortization	450	442
Depreciation and amortization expense	1,072	1,063
Provision for credit losses	298	729
Share-based compensation	967	619
Gains on sales of loans originated for sale	(268)	(60)
Fair value adjustments on loans held for sale	(18)	(325)
Mortgage loans originated for sale	(7,697)	(5,302)
Proceeds from sales of loans originated for sale	13,264	9,223
Net loss on disposal of premises and equipment	0	(11)
Deferred income tax expense	891	1,251
Investment securities losses	5	8
Return on investments in limited partnerships	(16)	(12)
Net unrealized (gains) losses on derivatives	(130)	279
Income from life insurance	(634)	(590)
(Increase) decrease in accrued interest receivable and other assets	(1,139)	1,294
Decrease in accrued interest payable and other liabilities	(3,092)	(12,522)
Other, net	186	172
Net cash provided by operating activities	12,670	5,414
Cash flows from investing activities
Maturities, repayments and calls of AFS securities	18,134	11,132
Purchases of AFS securities	(21,784)	(9,532)
Net redemptions (purchases) of restricted investments in bank stocks	539	(2,227)
Net (contributions to) distributions from investments in limited partnerships	(21)	321
Net increase in loans	(6,185)	(56,061)
Purchases of bank premises and equipment	(63)	(248)
Proceeds from disposal of premises and equipment	0	12
Net cash used in investing activities	(9,380)	(56,603)
Cash flows from financing activities
Net increase in deposits	137,137	39,377
Net (decrease) increase in borrowings with original maturities less than 90 days	(20,186)	13,038
Proceeds from FHLB advances with original maturities greater than 90 days	0	40,000
Payments on FHLB advances with original maturities greater than 90 days	0	(113)
Dividends paid	(2,123)	(2,126)
Acquisition of treasury stock	0	(1,175)
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(637)	(378)
Proceeds from issuance of employee stock purchase plan shares	80	66
Net cash provided by financing activities	114,271	88,689
Net increase in cash and cash equivalents	117,561	37,500
Cash and cash equivalents at beginning of period	65,161	60,823
Cash and cash equivalents at end of period	182,722	98,323
Cash paid during the period for:
Interest	15,894	7,046
Supplemental schedule of noncash activities:
OREO acquired in settlement of loans	0	85
Deposits held for assumption in connection with sale of bank branch	$ 0	$ 27,517